Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

Samsung Medical Center

Status: Unknown

Conditions: Intracranial Hemorrhages; Mesenchymal Stem Cells; Newborn Infant

Treatments: Other: observation without intervention in this follow up study

Study type: Observational

Funder types: Other

Identifiers

NCT02673788

2015-09-102

Details and patient eligibility

About

This is a follow-up study of the open label, single-center, phase I clinical trial to evaluate the safety of Pneumostem® in premature infants with Intraventricular hemorrhage.

Enrollment: 9 estimated patients

Sex: All

Ages: 6 months to 2 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.

Exclusion criteria

• Patients who did not enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.